Philipp Probst | Director ADC Research
Araris Biotech AG

Philipp Probst is Director of ADC Research at Araris Biotech AG, a Swiss biotech company located in Au ZH pioneering a novel linker technology for antibody-drug conjugates. He studied Pharmaceutical Sciences and received his PhD from ETH Zürich in 2018, where he worked in the group of Prof. Dario Neri on the generation of antibody-targeted therapeutics for applications in oncology. Philipp joined Araris in 2019 and focuses on the development of novel ADC candidates using the Araris Linker Technology.